AGAWAM, Mass., June 3 /PRNewswire/ -- Microtest Laboratories (http://www.microtestlabs.com) has doubled their microbial identification and analytical services with the purchase of an additional MicroSeq(R) Microbial Identification System.
The MicroSeq is a state-of-the-art DNA sequence-based system that enables Microtest technicians to more quickly and accurately identify bacteria isolates that are not viable or easily identified.
"With the purchase of our second MicroSeq system, we are not only complimenting our existing unit but doubling our analytical capacity and ability to service our clients," stated Dr. Steven Richter, Microtest President and Chief Scientific Officer. "As one of the only testing labs in the area with this technology, we are providing our customers with a significant competitive advantage."
Using the MicroSeq system, Microtest technicians can provide precise and reliable bacteria, mycoplasma, and mold identification in a 24-hour time period. Traditional bacteria and mold identification lab tests are often less accurate, and require up to a one-week turn around time.
"In the highly competitive biotechnology industry, accuracy and speed cannot be compromised," stated Dr. Richter. "Our ability to provide rapid identification helps our customers minimize down-time, which directly affects their bottom-line. When manufacturing is halted or a cleanroom is shut-down and awaiting test results, there is no product going out the door and that translates to an interruption in sales."
The MicroSeq system is integrated for use across the spectrum of
services that Microtest provides. Customers that will benefit most are
those that utilize their analytical testing services in:
-- Contract Manufacturing
-- Pharmaceutical Testing & Validation
-- Medical Device Testing & Validation
-- Environmental Control and Testing
|SOURCE Microtest Laboratories|
Copyright©2008 PR Newswire.
All rights reserved